Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for medical industry professionals · Monday, December 17, 2018 · 471,342,014 Articles · 3+ Million Readers

Asia Pacific Offers The Best Opportunities For Pharma Companies, Says TBRC

Pharmaceutical Drugs Market Size By Regions

Pharmaceutical Drugs Market Size By Regions

LONDON, GREATER LONDON, UK, April 12, 2018 / -- At 8.4% per annum the market for medical drugs is growing faster in the Asia-Pacific region than any other in the world, a report from The Business Research Company shows. North America (the USA, Canada, and Mexico) will continue to be the largest regional markets for the pharma companies, worth $416 billion a year by 2021, with the Asia Pacific in next place with $277 billion of annual sales. Growth has been and will continue to be spread across all regions of the world, though faster in some than others. North America's growth will be only 5.1% a year, below the global average, while Western Europe is expected to have the lowest annual growth rate of 3.9% from 2017 to 2021. Its share in the global market in 2017 was 19.4%, worth $180.9 billion. It is expected to grow to $211 billion by 2021.

The pharmaceutical drugs industry comprises establishments that develop drugs to diagnose, cure, treat or prevent diseases. Pharmaceutical companies produce both generic and branded drugs. Pharmaceutical drugs are subject to a number of laws and regulations that deal with patenting, testing, safety, efficacy and marketing and affect the size and growth rates of the market. Pharmaceutical companies produce pharmaceutical drugs made from active pharmaceutical ingredients (API) and excipients.

The fastest-growing pharma segment will be that for metabolic disorders (to treat conditions such as diabetes and disorders of the thyroid and pituitary gland) but this will still in 2021 be in fifth place for market size behind the musculoskeletal, oncology, cardiovascular and anti-infective drug markets.

Rising GDP per capita making drugs and treatment more affordable in the emerging regions like Asia Pacific and population aging leading to higher incidence of chronic disease in the developed regions are the primary factors leading to the growth of pharma markets.

The leading pharma companies are Swiss company Novartis, with just under 5% of the global market in 2017, followed by Sanofi, which is French, then Hoffmann-La Roche, Swiss again. The top ten pharmaceutical manufacturers shared a little over 30% of the global market between them.

Where to Learn More
Read the Pharmaceutical Drugs Market Report from The Business Research Company for information on the following:
Markets Covered: Musculoskeletal Disorder Drugs, Cardiovascular Drugs, Oncology Drugs, Anti-infective Drugs, Metabolic Disorder Drugs, Central Nervous System Drugs, Genito-urinary Drugs, Gastrointestinal Drugs, Hematology Drugs, Dermatology Drugs, Ophthalmology Drugs, Drugs For Respiratory Diseases.
Pharmaceutical Companies Mentioned: Novartis AG, Sanofi S.A., F. Hoffman-La Roche Ltd., Pfizer Inc. and Gilead Sciences Inc.
Countries: India, China, Japan, Australia, UK, Germany, France, Italy, Spain, Russia, USA, Brazil
Regions: North America, South America, Western Europe, Eastern Europe, Africa, Middle East, Asia Pacific
Time Series: Five years historic and forecast.
Data: Ratios of market size and growth to related markets, population, GDP, Pharmaceutical Drugs Indicators Comparison.
Data Segmentations: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report are sourced using endnotes.

Oliver Guirdham
The Business Research Company
+44 207 1930 708
email us here

Powered by EIN Presswire

EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release